Search

Learn why medical oncologist Ghassan Abou-Alfa counsels his patients with liver cancer to stop drinking.

Inheriting a mutation in the CDH1 gene can raise risk of a rare stomach cancer called hereditary diffuse gastric cancer.

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

Researchers learn how prostate cancer cells change their type to survive treatment.

By identifying mutations found in a person’s cancer, this blood test can help doctors tailor treatments to those most likely to benefit.

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.

Get to know Ashley Chui, a chemical biology graduate student in the Sloan Kettering Institute.

Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine, will also be honored with the 2021 Honorary Degree and the MSK Medal for Outstanding Contributions to Biomedical Research.